These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 23796281)

  • 1. Validation of electronic systems to collect patient-reported outcome (PRO) data-recommendations for clinical trial teams: report of the ISPOR ePRO systems validation good research practices task force.
    Zbrozek A; Hebert J; Gogates G; Thorell R; Dell C; Molsen E; Craig G; Grice K; Kern S; Hines S
    Value Health; 2013 Jun; 16(4):480-9. PubMed ID: 23796281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report.
    Coons SJ; Gwaltney CJ; Hays RD; Lundy JJ; Sloan JA; Revicki DA; Lenderking WR; Cella D; Basch E;
    Value Health; 2009 Jun; 12(4):419-29. PubMed ID: 19900250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force.
    Matza LS; Patrick DL; Riley AW; Alexander JJ; Rajmil L; Pleil AM; Bullinger M
    Value Health; 2013 Jun; 16(4):461-79. PubMed ID: 23796280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRO data collection in clinical trials using mixed modes: report of the ISPOR PRO mixed modes good research practices task force.
    Eremenco S; Coons SJ; Paty J; Coyne K; Bennett AV; McEntegart D;
    Value Health; 2014 Jul; 17(5):501-16. PubMed ID: 25128043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ePRO systems validation: clearly defining the roles of clinical trial teams and ePRO system providers.
    Coons SJ
    Value Health; 2013 Jun; 16(4):457-8. PubMed ID: 23796278
    [No Abstract]   [Full Text] [Related]  

  • 7. Training on the Use of Technology to Collect Patient-Reported Outcome Data Electronically in Clinical Trials: Best Practice Recommendations from the ePRO Consortium.
    Ly JJ; Crescioni M; Eremenco S; Bodart S; Donoso M; Butler AJ; Dallabrida SM
    Ther Innov Regul Sci; 2019 Jul; 53(4):431-440. PubMed ID: 30221997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The patient-reported outcome (PRO) consortium: filling measurement gaps for PRO end points to support labeling claims.
    Coons SJ; Kothari S; Monz BU; Burke LB
    Clin Pharmacol Ther; 2011 Nov; 90(5):743-8. PubMed ID: 21993428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electronic patient-reported outcome systems in oncology clinical practice.
    Bennett AV; Jensen RE; Basch E
    CA Cancer J Clin; 2012; 62(5):337-47. PubMed ID: 22811342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Documentation in the cardiac catheterization laboratory using electronic databases--experiences in 176 German cath labs].
    Wiesmann F; Heinrich D; Greger H; Ertl G; Voelker W
    Z Kardiol; 2003 Jul; 92(7):571-80. PubMed ID: 12883842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Best Practice Recommendations for Electronic Patient-Reported Outcome Dataset Structure and Standardization to Support Drug Development.
    Hudgens S; Kern S; Barsdorf AI; Cassells S; Rowe A; King-Kallimanis BL; Coon C; Low G; Eremenco S
    Value Health; 2023 Aug; 26(8):1242-1248. PubMed ID: 36849080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical applications of usability theory to electronic data collection for clinical trials.
    Schmier JK; Kane DW; Halpern MT
    Contemp Clin Trials; 2005 Jun; 26(3):376-85. PubMed ID: 15911471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Best Practice Recommendations: User Acceptance Testing for Systems Designed to Collect Clinical Outcome Assessment Data Electronically.
    Gordon S; Crager J; Howry C; Barsdorf AI; Cohen J; Crescioni M; Dahya B; Delong P; Knaus C; Reasner DS; Vallow S; Zarzar K; Eremenco S;
    Ther Innov Regul Sci; 2022 May; 56(3):442-453. PubMed ID: 35233726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multinational trials-recommendations on the translations required, approaches to using the same language in different countries, and the approaches to support pooling the data: the ISPOR Patient-Reported Outcomes Translation and Linguistic Validation Good Research Practices Task Force report.
    Wild D; Eremenco S; Mear I; Martin M; Houchin C; Gawlicki M; Hareendran A; Wiklund I; Chong LY; von Maltzahn R; Cohen L; Molsen E
    Value Health; 2009 Jun; 12(4):430-40. PubMed ID: 19138309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electronic patient-reported data capture as a foundation of rapid learning cancer care.
    Abernethy AP; Ahmad A; Zafar SY; Wheeler JL; Reese JB; Lyerly HK
    Med Care; 2010 Jun; 48(6 Suppl):S32-8. PubMed ID: 20473201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of the Task Force Report on PRO data collection in clinical trials using mixed modes.
    McLeod L
    Value Health; 2014 Jul; 17(5):491-2. PubMed ID: 25128040
    [No Abstract]   [Full Text] [Related]  

  • 19. Selection of and Evidentiary Considerations for Wearable Devices and Their Measurements for Use in Regulatory Decision Making: Recommendations from the ePRO Consortium.
    Byrom B; Watson C; Doll H; Coons SJ; Eremenco S; Ballinger R; Mc Carthy M; Crescioni M; O'Donohoe P; Howry C;
    Value Health; 2018 Jun; 21(6):631-639. PubMed ID: 29909867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.